0, 6% af patienterne i behandling med aprepitant sammenlignet med 0, 4% af patienterne i standardbehandling.
Aprepitant was discontinued due to adverse reactions in 0.6% of patients treated with the aprepitant regimen compared with 0.4% of patients treated with standard therapy.